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Abstract: Introduction: Midazolam has turned into a common drug for pediatric procedural sedation and analgesia.
However, there is not much data regarding its proper dose and potential side effects in the Iranian children
population. Therefore, the present study was done to compare 2 doses of IV midazolam in this regard. Methods:
The present clinical trial was performed to compare 0.1 and 0.3 mg /kg doses of IV midazolam in induction of
sedation for head trauma infant patients in need of brain computed tomography (CT) scan. Conscious infants
under 2 years old, with stable hemodynamics were included. Onset and duration of action as well as probable
side effects were compared between the two groups using SPSS version 22. Results: 110 infants with the mean
age of 14.0±5.9 months (range: 4–24) and mean weight of 9.7±2 kg (range: 5–15) were randomly allocated to
one of the 2 study groups (54.6% female). Success rate in 0.1 and 0.3 mg /kg groups were 38.2% (21 patients)
and 60% (33 patients), respectively (p = 0.018). Overall, 56 (50.9%) patients did not reach proper sedation and
were sedated receiving ketamine (22 patients) or another dose of midazolam (34 patients, mean additional dose
needed was 2.1±1.1 mg ). Conclusion: The results of the present study demonstrated the higher success rate and
longer duration of action for 0.3 mg /kg midazolam compared to 0.1 mg /kg . The groups were equal regarding
onset of action, effect on vital signs and probable side effects.
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1. Introduction
S
edation induction is one of the most important and
sometimes most difficult stages of carrying out a diag-
nostic or therapeutic procedure in children (1). Chil-
dren not cooperating for diagnostic evaluations such as com-
puted tomography (CT) scan and magnetic resonance imag-
ing are among the most common cases of using procedu-
ral sedation and analgesia (PSA) in emergency departments
(ED). An ideal sedative drug should be rapid and short-
acting, with minimum side effects on the patients respiratory
condition and hemodynamic.
Various drugs such as chloral hydrate, phenobarbital, propo-
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fol, midazolam, and etomidate are among the available drugs
for this purpose Yet, selection of the safest and most efficient
drug and its proper dose for sedation are a matter of debate
(1–4). Many of pediatric patients do not receive enough drug
due to concerns about probable side effects of the drug (5).
Midazolam has turned into a common drug for induction of
sedation in EDs as a result of its short half-life, various meth-
ods of prescription and less pain at the time of injection. This
relatively short-acting benzodiazepine has anti-stress, seda-
tive, anti-seizure, and muscle relaxant effects.
Singh et al. showed that use of intravenous (IV) midazo-
lam with a 0.2 mg /kg dose, can induce proper sedation with
minimum side effects for pediatric imaging (6). However,
there is not much data regarding its proper dose and poten-
tial side effects especially in the Iranian children population.
Therefore, the present study was done to compare 2 doses of
IV midazolam in sedation induction for doing brain imaging
in infants.
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2. Methods
2.1. Study design
The present clinical trial was performed to compare 0.1 and
0.3 mg /kg doses of IV midazolam in induction of seda-
tion for infants in need of brain CT scan following head
trauma. The infants presented to the ED of Golestan and
Imam Khomeini Hospitals, Ahvaz, Iran, during April 2014
to March 2015 were studied. After completely explaining
the study protocol to the parents, informed consent form
was filled for each participant to enter the study. All the
researchers adhered to Helsinki declaration. If the parents
were not content with the study process or did not want
their infant to continue participating at any stage, the infant
was excluded. The present study has been registered on the
Iranian Registry of Clinical Trials (IRCT) under the number
IRCT201592121289N2 and approved by the Ethics Commit-
tee of Ahvaz Jundishapour University of Medical Sciences.
2.2. Participants
Infants presented to the ED following head trauma in need
of sedation induction for undergoing brain CT scan were
enrolled. Conscious infants under 2 years old, with stable
hemodynamics were included. Exclusion criteria consisted
of high probability of difficult airway, history of uremia and
allergy to benzodiazepine, presence of hemodynamic insta-
bility, congestive heart failure, liver diseases, decreased level
of consciousness, uncontrolled vomiting, history of reflux,
and simultaneous use of opioids.
2.3. Procedure
All patients were prepared with a proper peripheral IV line
and continuous heart, blood pressure, pulse rate, and pulse
oximetry monitoring. Participants underwent low-flow oxy-
gen therapy via nasal cannula during the procedure. They
were divided into equal groups of A and B, using 4-block
randomization. Group A, received IV midazolam with 0.1
mg /kg dose, while the dose was 0.3 mg/kg for group B. The
goal was reaching sedation level of 3 or 4 based on Ramsay
scale (7). Not reaching the desired level of sedation was con-
sidered as sedation failure. In these cases IV ketamine with
1 mg /kg dose or another dose of midazolam was used. All
injections were done via the peripheral vessel using a blue or
yellow angiocatheter, and slowly during 10 seconds. Brain CT
scan indication was decided by an emergency medicine spe-
cialist based on the standard protocols of advanced trauma
life support (ATLS). Injections were done by trained nurses
under supervision of a senior emergency medicine resident.
Over the course of the procedure, all the required equip-
ment for probable need for airway management were present
at the patients bedside. Midazolam ampule containing 5
mg /cc was used. We should note that the physician prescrib-
Table 1: Baseline characteristics of studied patients
Variable Groups P value
0.1 mg /kg 0.3 mg /kg
Sex
Boy 26 (47.3) 24 (43.6) < 0.424
Girl 29 (52.7) 31 (56.4)
Age (Month) 15.7±5.4 12.4±6.0 0.003
Weight (K g ) 9.8±1.9 9.5±2.0 0.465
The number of patients in each group = 55; measures pre-
sented as number (%) or mean ± standard deviation.
ing the drugs and the patientsâĂŹ parents were blinded to the
drug dose.
2.4. Data gathering
A checklist consisting of demographic data and pharmaco-
dynamics (onset and duration of action and side effects) was
filled for all the patients in both groups. Drop of oxygen sat-
uration to < 95, decreased blood pressure, inconsolable cry-
ing, restlessness and anxiety, hiccup, opisthotonus, seizure,
nausea and vomiting, and respiratory depression and apnea
were among the studied side effects.
2.5. Statistical analysis
Data were analyzed using SPSS statistical software version 22.
Quantitative data were reported as frequency and percent-
age, and qualitative ones as mean ± standard deviation. Chi-
square and Independent sample t-test were used for compar-
ing data between two groups. P < 0.05 was considered as sig-
nificance level.
3. Results
110 infants with the mean age of 14.0± 5.9 months (range:
4–24) and mean weight of 9.7 ± 2 kg (range: 5–15) were
randomly allocated to one of the 2 study groups (54.6% fe-
male). Table 1 shows the baseline characteristics of the pa-
tients. Success rate in 0.1 and 0.3 mg /kg groups were 38.2%
(21 patients) and 60% (33 patients), respectively (p = 0.018).
Overall, 56 (50.9%) patients did not reach proper sedation
and were sedated receiving ketamine (22 patients) or an-
other dose of midazolam (34 patients, mean additional dose
needed was 2.1±1.1 mg ). Table 2 compares the therapeutic
characteristics and side effects of the 2 doses of midazolam.
4. Discussion
The results of the present study demonstrated the higher suc-
cess rate and longer duration of action for 0.3 mg /kg mida-
zolam compared to 0.1 mg /kg . The groups were equal re-
garding onset of action, effect on vital signs and probable side
effects.
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Table 2: Baseline characteristics of studied patients
Variable Groups P value
0.1 mg /kg 0.3 mg /kg
Sex
Boy 26 (47.3) 24 (43.6) < 0.424
Girl 29 (52.7) 31 (56.4)
Age (Month) 15.7±5.4 12.4±6.0 0.003
Weight (K g ) 9.8±1.9 9.5±2.0 0.465
The number of patients in each group = 55; measures pre-
sented as number (%) or mean ± standard deviation.
Facing children in ED has always been special. Presentation
of a pediatric trauma patient, accompanied by restless par-
ents, to an overcrowded ED has been a nightmare for emer-
gency medicine physicians, especially if a diagnostic and
therapeutic procedure is required. The need for keeping the
child motionless during procedures, has made using PSA in-
evitable for this age group. Being familiar with various kinds
of available drugs and their dosage is a necessary skill for all
emergency physicians. Therefore, the present study was de-
signed and carried out to compare the effectiveness and side
effects of two different IV midazolam doses.
In the study by Singh et al., midazolam’s onset of action was
shorter than this study (6). This difference may be due to
the differences in age distribution of the participants in the 2
studies and the chief complaints on admission. In both stud-
ies, a relatively significant number of the patients needed ad-
ditional doses to reach proper sedation and a single dose of
the drug had a significant failure rate. In addition, in a study
by Sutherland et al., use of 0.2 mg /kg alone was not enough
to induce proper sedation for undergoing CT scan in most
children; it was efficient for only 19% of them (2). Regard-
ing onset of action, the results of the present study were in
line with those of Jevdjic et al. in their 2011 study, especially
in the 0.1 mg /kg dose (8). Additionally, regarding proba-
ble side effects and effects on vital signs a thorough corre-
lation was seen between the results of this study and Rah-
man study (9). Treatment success rate in this study was less
than 50% for both doses. This means that about half the pa-
tients need higher doses of midazolam or other drugs such
as ketamine to reach the proper level of sedation. The re-
sults of a review study in 2007 showed that despite the similar
effects of midazolam and ketamine, ketamine was the drug
of choice for both parents and physicians to sedate children
(10). Therefore, it seems that although midazolam is safe and
emergency physicians are familiar with its probable side ef-
fects, its success rate, at least with the doses mentioned in the
present study, is not high. Therefore, we should either revise
the dose of this drug, or use other drugs with higher success
probability. The importance of this matter is that most of the
time, when children are not sedated with the initial injection,
it makes the parents more anxious and therefore makes the
atmosphere more chaotic. It is suggested to carry out other
trials with various doses and bigger sample size, to find the
proper dose of drug. Parents not being content about their
children participating in the study was among the limitations
of the present study, which made case collection somehow
difficult.
5. Conclusion
The results of the present study demonstrated the higher suc-
cess rate and longer duration of action for 0.3 mg /kg mida-
zolam compared to 0.1 mg /kg . The groups were equal re-
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